Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'.
Anastasios KyriazoglouPieter JespersVincent VandecavayeOlivier MirBernd KasperZsuzsanna PapaiJean Yves BlayAntoine ItalianoFacundo ZaffaroniSaskia LitièreAxelle NzokirantevyePatrick SchöffskiPublished in: Acta oncologica (Stockholm, Sweden) (2022)
EORTC 1317, NCT02216578.